Merck | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
AbbVie USD 3.32B 2.71B 2024-12
Abbott USD 49.06B 9.04B 2025-03
ALKERMES USD 1.46B 172.88M 2024-12
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 41.04B 168M 2025-03
Biogen USD 16.72B 357.1M 2024-12
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Indivior -285000000 63M 2025-03
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 49.39B 893M 2025-01
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Novo Nordisk 120.52B 8B 2024-09
Pacira USD 778.35M 28.76M 2024-12
Perrigo USD 4.32B 246.6M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Prestige Brands USD 1.79B 56.67M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
Sanofi 77.86B 4.86B 2024-12
United Therapeutics USD 6.81B 363.2M 2025-03
Zoetis USD 4.77B 464M 2024-12



Merck Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.